| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |